Results 121 to 130 of about 808,349 (313)

White Matter and Perivascular Imaging Changes in Alzheimer's Disease and Cerebral Amyloid Angiopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Peak‐width of skeletonized mean diffusivity (PSMD) and diffusion tensor imaging–analysis along the perivascular space (DTI‐ALPS), reflecting white matter integrity and glymphatic function, are altered in Alzheimer's disease (AD).
Debina Laishram   +3 more
wiley   +1 more source

Additional file 3: of Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

open access: yes, 2018
Figure S6. Distribution of TIS scores within two MSI status categories and three cancer types. Points show individual samplesâ TIS scores. (PDF 31 kb)
Danaher, Patrick   +8 more
openaire   +1 more source

A rack of ATLAS TDAQ components

open access: yes, 2014
A rack of ATLAS TDAQ ...
ATLAS, Experiment
core  

Metabolic and Fluid Biomarkers Support Microglia Activation in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis is an incurable neurodegenerative disease involving motor neuron degeneration and metabolic and immune dysfunction. We combined clinical data, cerebrospinal fluid biomarkers and fluorodeoxyglucose positron emission tomography with magnetic resonance imaging to investigate the role of reactive microglia in disease ...
Matteo Zanovello   +10 more
wiley   +1 more source

Additional file 7: of Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

open access: yes, 2018
Figures. S8â S39. Checkpoints versus TIS score in all tumor types. (PDF 701 kb)
Danaher, Patrick   +8 more
openaire   +1 more source

ATLAS event displays of lead-lead ion collisions in ATLAS detector during Run 3

open access: yes, 2022
First ATLAS event displays of heavy ion collisions (lead-lead or Pb-Pb particles) events of Run 3. LHC experiments received a heavy ion beam during 3 days (17 to 19 November)
ATLAS Collaboration
core  

Clinical Validation of Artificial Intelligence (AI)‐based Cartilage Segmentation Predicting Knee Replacement

open access: yesArthritis Care &Research, Accepted Article.
Objective For cartilage morphology to serve as a scalable endpoint in clinical trials, analyses should be performed automatically without human interaction. To clinically validate artificial intelligence (AI)‐based analysis, we studied cartilage loss from MRI prior to knee replacement.
Felix Eckstein   +3 more
wiley   +1 more source

Additional file 1: of Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

open access: yes, 2018
Figure S7. Distribution of TIS scores in stage IV disease. TIS scores are shown for all TCGA patients with stage 4 disease. Cancer types are ordered by median TIS score in all patients, identical to Fig. 1. (PDF 30 kb)
Danaher, Patrick   +8 more
openaire   +1 more source

Workflow for Design of Experiments‐Based Modeling of Species Transport and Growth Kinetics in GaN Hydride Vapor Phase Epitaxy

open access: yesAdvanced Engineering Materials, EarlyView.
A novel workflow for investigating hydride vapor phase epitaxy for GaN bulk crystal growth is proposed. It combines Design of experiments (DoE) with physical simulations of mass transport and crystal growth kinetics, serving as an intermediate step between DoE and experiments.
J. Tomkovič   +7 more
wiley   +1 more source

ATLAS/ti: ein Werkzeug für die Textinterpretation

open access: yes, 1994
Der Beitrag stellt das System ATLAS/ti für die computerunterstützte Textinterpretation vor. Ausgangspunkt für die Entwicklung der Software war die Erfahrung von Sozialwissenschaftlern, in der für qualitativ orientierte Untersuchungen typischen Datenfülle regelrecht zu ertrinken ("Zettels (Alb-) Traum").
openaire   +1 more source

Home - About - Disclaimer - Privacy